Updated: Fri, 10/11/2024 - 12:00

Campus/building access, classes and work will return to usual conditions, as of Saturday, Oct. 12. See Campus Public Safety website for details.


Accès au campus et aux immeubles, cours et modalités de travail : retour à la normale à compter du samedi 12 octobre. Complément d’information : Direction de la protection et de la prévention.

Pharmacology & Therapeutics Platforms

From molecules to tissues: Imaging & Molecular Biology Platform (IMBP), Surface Plasmon Resonance - Mass Spectrometry (SPR-MS) Facility, and Electron Microscopy (EM) services.

 

Tags: Department of Pharmacology & Therapeutics, transmission electron microscopy, TEM, pre-embedding immunocytochemistry, post-embedding immunocytochemistry, flat embedding, epoxy resin, methacrylate resin, negative staining, ultramicrotomy, processing cells & tissues, Imaging & Molecular Biology Platform, IMBP, Confocal and Two-Photon Microscopy, High Content Imaging, PCR, qPCR, Bioanalyzer, Microarray, Pyrosequencing, McGill SPR-MS Facility, surface plasmon resonance, SPR, BIACORE 3000, BIACORE T200, mass spectrometry, MS, Bruker UltrafleXtreme, MALDI-TOF/TOF, MALDI tissue imaging, mass spectrometry imaging, IMS, MSI, top-down sequencing, TDS, in-source decay, ISD, Bruker Impact II, ESI-qTOF, LC-MS, LC-MS/MS, in-gel trypsin digestion, in-solution trypsin digestion

Back to top